Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Cottrell

Showing results (101-110 of 139) with videos related to

Pageof 14
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 2, 2017
Implications of the tumor immune microenvironment for staging and therapeuticsJanis M Taube, Jérôme Galon, Lynette M Sholl, et al.
Nature Communications|September 28, 2019
Multiplexed and high-throughput neuronal fluorescence imaging with diffusible probesSyuan-Ming Guo, Remi Veneziano, Simon Gordonov, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 29, 2019
Major pathologic response on biopsy (MPRbx) in patients with advanced melanoma treated with anti-PD-1: evidence for an early, on-therapy biomarker of responseJ E Stein, A Soni, L Danilova, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 22, 2017
PD-L1 Expression in Melanoma: A Quantitative Immunohistochemical Antibody ComparisonJoel C Sunshine, Peter L Nguyen, Genevieve J Kaunitz, et al.
JAMA Oncology|March 24, 2017
Association of HIV Status With Local Immune Response to Anal Squamous Cell Carcinoma: Implications for ImmunotherapyElizabeth L Yanik, Genevieve J Kaunitz, Tricia R Cottrell, et al.
Nucleic Acids Research|May 14, 2020
MISCAST: MIssense variant to protein StruCture Analysis web SuiTeSumaiya Iqbal, David Hoksza, Eduardo Pérez-Palma, et al.
International Journal of Cancer|November 11, 2006
Inflammation and IGF-I activate the Akt pathway in breast cancerRobyn L Prueitt, Brenda J Boersma, Tiffany M Howe, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 27, 2020
Comprehensive characterization of amino acid positions in protein structures reveals molecular effect of missense variantsSumaiya Iqbal, Eduardo Pérez-Palma, Jakob B Jespersen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 2, 2019
Pan-Tumor Pathologic Scoring of Response to PD-(L)1 BlockadeJulie E Stein, Evan J Lipson, Tricia R Cottrell, et al.
Clinical Lung Cancer|October 11, 2024
A Phase II Study of Neoadjuvant Opnurasib KRAS G12C Inhibitor in Patients With Surgically Resectable Non-Small Cell Lung Cancer (CCTG IND.242A): A Substudy of the IND.242 Platform Master ProtocolJ Spicer, N Blais, S Owen, et al.
Pageof 14

Showing results (101-110 of 139) with videos related to

Sort By:
Pageof 14
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 2, 2017
Implications of the tumor immune microenvironment for staging and therapeuticsJanis M Taube, Jérôme Galon, Lynette M Sholl, et al.
Nature Communications|September 28, 2019
Multiplexed and high-throughput neuronal fluorescence imaging with diffusible probesSyuan-Ming Guo, Remi Veneziano, Simon Gordonov, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 29, 2019
Major pathologic response on biopsy (MPRbx) in patients with advanced melanoma treated with anti-PD-1: evidence for an early, on-therapy biomarker of responseJ E Stein, A Soni, L Danilova, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 22, 2017
PD-L1 Expression in Melanoma: A Quantitative Immunohistochemical Antibody ComparisonJoel C Sunshine, Peter L Nguyen, Genevieve J Kaunitz, et al.
JAMA Oncology|March 24, 2017
Association of HIV Status With Local Immune Response to Anal Squamous Cell Carcinoma: Implications for ImmunotherapyElizabeth L Yanik, Genevieve J Kaunitz, Tricia R Cottrell, et al.
Nucleic Acids Research|May 14, 2020
MISCAST: MIssense variant to protein StruCture Analysis web SuiTeSumaiya Iqbal, David Hoksza, Eduardo Pérez-Palma, et al.
International Journal of Cancer|November 11, 2006
Inflammation and IGF-I activate the Akt pathway in breast cancerRobyn L Prueitt, Brenda J Boersma, Tiffany M Howe, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 27, 2020
Comprehensive characterization of amino acid positions in protein structures reveals molecular effect of missense variantsSumaiya Iqbal, Eduardo Pérez-Palma, Jakob B Jespersen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 2, 2019
Pan-Tumor Pathologic Scoring of Response to PD-(L)1 BlockadeJulie E Stein, Evan J Lipson, Tricia R Cottrell, et al.
Clinical Lung Cancer|October 11, 2024
A Phase II Study of Neoadjuvant Opnurasib KRAS G12C Inhibitor in Patients With Surgically Resectable Non-Small Cell Lung Cancer (CCTG IND.242A): A Substudy of the IND.242 Platform Master ProtocolJ Spicer, N Blais, S Owen, et al.
Pageof 14